Dassault Systèmes SIMULIA is the simulation technology suite empowering the unique 3DEXPERIENCE platform. Applications in the SIMULIA portfolio enable engineers to test performance, reliability, and safety of materials and products while still in the virtual environment, saving time and money by reducing or eliminating physical prototypes.

SIMULIA simulation technology is available as specific products for targeted functions such as structural analysis, fluids, plastic injection molding, and acoustics. Specific Industry Solutions provide a set of interrelated analysis tools for Aerospace & Defense; Architecture, Engineering & Construction; Retail Consumer Goods; Retail Consumer Packaged Goods; Energy, Process, & Utilities; High Tech; Industrial Equipment; Life Sciences; Marine & Offshore; and Transportation & Mobility.

Like its counterpart CATIA for CAD; SIMULIA is available pre-configured for specific roles within the various Industry solutions. Available roles include Finite Element Modeling Specialist; Fluid Dynamics Engineer; Noise & Vibration Analyst; Plastic Injection Molding Engineer; Plastic Injection Part Engineer; Stress Engineer; Structural Analysis Engineer; and Structure Functional Analysis Engineer.

The SIMULIA portfolio includes many of the best-known brands in simulation and analysis technology, all now part of the 3DEXPERIENCE portfolio, including Abaqus FEA; fe-safe; Isight; Tosca; Simpack; Simpoe-Mold; and SIMULIA Simulation Lifecycle Management (SLA). All are also available for use with the CATIA V5 design environment.

SIMULIA technology run either on-premise or on-cloud, as the user requires. Simulation takes advantage of the design geometry, fully integrated with CAD and PLM. Simulation tasks are linked to the design at all times, making it easy to execute updates when the underlying design changes. Company-specific simulation best practices, standards, and algorithms can be integrated into the portfolio.

Simulation software is useless if it cannot be considered as authoritative and reliable. Dassault Systemès maintains a formal quality control system for all products in the SIMULIA portfolio. All products meet or exceed relevant ISO standards, including quality assurance criteria for nuclear power plants and computer software. The software also facilitates customer compliance with relevant standards, based on 10 CFR Part 21 (“Reporting of Defects and Noncompliances”). These efforts are resource-intensive, but absolutely essential to insure the quality and reliability of all SIMULIA simulation and analysis technology.

SIMULIA simulation and analysis technology empowers many of the world’s largest and most technically sophisticated manufacturing companies. Most PLM companies offer a CAD product on one hand and a data management product on the other hand. Only Dassault Systèmes offers the full array of value creation solutions for manufacturing as a comprehensive, integrated 3D environment, including simulation and analysis.

A variety of 3D dashboards provide a modern user experience both intuitive and powerful. The SIMULIA 3DEXPERIENCE platform is purpose-built to integrate into the larger Dassault Systemès value creation enterprise suite.

Video Transcription

For decades 3d modeling and realistic simulation technology have been used in the automotive, aerospace, energy, high-tech, and many other industries to virtually design and test products that we interact with every day.

So, what if we achieved the state whereby doctors could rely on the same technology for improving patient care?

The living heart project formed by SIMULIA the Dassault Systemes brand for realistic simulation set out to answer this very question.

By relying on the powerful 3DExperience platform and crucial input from leading engineers, medical professionals, and regulatory bodies, the project seeks to revolutionize patient care by utilizing these groups and technology to translate research discoveries into proven treatments.

During this experience we will take you on a journey into the future of medicine where physicians and surgeons will use advanced digital technology, such as dynamic 3D modeling and realistic simulation to treat patients.

In the future, we can imagine medical practitioners interacting with virtual patient models to perform non-invasive diagnostic studies.

These advancements will enable the exploration of entire biological systems of an individual patient.

In this next sequence let’s imagine a cardiologist having direct access to the cloud-based 3DExperience platform to compile diagnostic data, capture macro measurements in the heart to apply range specifications, target markers to capture micro movements in the heart, personalize a realistic human heart simulation using the gathered diagnostic and measurement data, analyze the behavior of the patient’s simulated heart to identify potential concerns, collaborate with other experts to explore treatment scenarios and search critical studies, and finally, simulate a variety of treatment scenarios to identify the optimal outcome for the patient.

The potential for this technology is immense.

For instance, here is an example of a realistic simulation of a healthy adult human heart.

Personalized patient models based on measured hard data can be validated against the performance at this healthy heart model for unprecedented insight into defects or future complications.

This technology will also enable cardiologists to perform deep, non-invasive studies to explore the behavior a patient’s heart.

Let’s take a moment to study the interior of a beating human heart with remarkable horizontal and vertical cut views.

In this example we can visualize the electrical potential and the mechanical deformation across the human heart throughout its cardiac cycle.

The last model we will study is what we refer to as the fantastic voyage of blood flowing through the heart.

First we will enter the heart through the Superior Vena Cava emptying oxygen poor blood from the body into the right atrium of the heart.

As the atrium contracts, we move from the right atrium into the right ventricle through the tricuspid valve.

When the ventricle is full the tricuspid valve shuts and prevents blood from flowing backwards into the atrium while the ventricle contracts.

As the ventricle contracts, we leave the heart through the pulmonic valve into the pulmonary artery and to the lungs where it is oxygenated.

Now we return to the heart by way of the pulmonary vein, which carries oxygen-rich blood from the lungs into the left atrium of the heart.

As the atrium contracts, we move from the left atrium into the left ventricle through the mitral valve.

When the ventricle is full the mitral valve shuts.

This prevents blood from flowing backward into the atrium while the ventricle contracts.

As the ventricle contracts we leave the heart through the aortic valve and proceed into the aorta and to the body.

We hope that this journey has inspired you to learn more about the living heart project.

For more information please visit 3ds.com/heart.